Skip to main content

Aureomycin 100 Granular

This page contains information on Aureomycin 100 Granular for veterinary use.
The information provided typically includes the following:
  • Aureomycin 100 Granular Indications
  • Warnings and cautions for Aureomycin 100 Granular
  • Direction and dosage information for Aureomycin 100 Granular

Aureomycin 100 Granular

This treatment applies to the following species:
Company: Zoetis

Caution: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

GUARANTEED AUREOMYCIN® CHLORTETRACYCLINE

Chlortetracycline

Type A Medicated Article

Active Drug Ingredient

Chlortetracycline calcium complex equivalent to 100 g chlortetracycline hydrochloride per lb.

Ingredients

Dried Streptomyces aureofaciens Fermentation Product and Calcium Sulfate.

For use in the manufacture of medicated animal feeds.

For use in dry feed only. Not for use in liquid medicated feeds.

Use Directions

Mix sufficient Aureomycin 100 Granular Medicated Article to supply desired concentration of chlortetracycline per ton with part of the feed ingredients to make a preblend. Add the remainder of the ingredients and mix thoroughly. For specific use levels, see Indications for use.

Mixing directions

Level desired grams per ton

Amount of medicated article per ton

50

1/2 lb

100

1 lb

200

2 lb

400

4 lb

500

5 lb

It is recommended that 1 pound of Aureomycin 100 Granular Type A Medicated Article be diluted with 3 pounds of one of the feed ingredients to form a 4 pound working premix. Use 2 pounds of the working premix to make a preblend (see Use directions) for a Type C feed containing 50 g Aureomycin chlortetracycline / ton of feed.

Indications for use

Chlortetracycline
mg per lb body wt per day

Cattle

Beef Cattle (over 700 lb): Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline.

0.5

Beef and Non-Lactating Dairy Cattle: As an aid in control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline when delivered in a free-choice feed. Free-choice feed must be manufactured under a medicated feed mill license utilizing an FDA approved formulation.

0.5-2.0

Calves, Beef and Non-Lactating Dairy Cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. Feed for not more than 5 days. The appropriate amount of Aureomycin-containing feed supplement may be mixed in the cattle’s daily ration or administered as a top-dress. If the Aureomycin-containing feed supplement is administered as a top-dress, it must be spread uniformly on top of the ration and sufficient space must be provided so that all cattle can eat at the same time.

10

Swine

Control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline.

Treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. (Note: this drug level is equivalent to approximately 400 grams per ton, depending on feed consumption and body weight.)

Feed for not more than 14 days.

10

Turkeys

Control of complicating bacterial organisms associated with bluecomb (transmissible enteritis; coronaviral enteritis) susceptible to chlortetracycline.

Feed continuously for 7 to 14 days.

25


Indications for use

mg per head per day

Cattle

Growing Cattle (over 400 lb): For the reduction of the incidence of liver abscesses.

70

Beef Cattle and Dairy Replacement Heifers: Control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline.

350

Beef Cattle (under 700 lb): Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline.

350

Sheep

Breeding Sheep: Reduction in the incidence of (vibrionic) abortions caused by Campylobacter fetus infection susceptible to chlortetracycline.

80


Indications for use

In complete feed
Chlortetracycline g per ton

Swine

Reduction in the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci susceptible to chlortetracycline.

50-100

Breeding Swine: Control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline.

Feed continuously for not more than 14 days.

400

Ducks

Control and treatment of fowl cholera caused by Pasteurella multocida susceptible to chlortetracycline. Feed in complete ration to provide from 8 to 28 mg per pound of body weight per day depending upon age and severity of disease. Feed for not more than 21 days.

200-400

Chickens

Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline.

Feed continuously for 7 to 14 days.

100-200

Control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to chlortetracycline.

Feed continuously for 7 to 14 days.

200-400

Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline. Feed for 5 days.

500

Turkeys

Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline. Feed continuously for 7 to 14 days.

200

Control of hexamitiasis caused by Hexamita meleagridis susceptible to chlortetracycline. Feed continuously for 7 to 14 days.

400

Turkey Poults not over 4 weeks of age: Reduction of mortality due to paratyphoid caused by Salmonella typhimurium susceptible to chlortetracycline.

400


Indications for use

mg per g feed

Psittacine birds

Warning: Psittacosis, avian chlamydiosis, or ornithosis is a reportable communicable disease, transmissible between wild and domestic birds, other animals and man. Contact appropriate public health and regulatory officials.

Aureomycin 100 Granular Caution

Aspergilliosis may occur following prolonged treatment.

 

Treatment of psittacine birds (parrots, macaws, cockatoos) suspected or known to be infected with psittacosis caused by Chlamydia psittaci sensitive to chlortetracycline. Feed continuously for 45 days. Each bird should consume an amount of medicated feed equal to one-fifth of its body weight daily. During treatment, parrots, macaws, and cockatoos should be kept individually or in pairs in clean cages.

10


Withdrawal Periods And Residue Warnings

No withdrawal period is required when used according to labeling. This drug is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal. Do not feed to ducks or turkeys producing eggs for human consumption.

Store below 25°C (77°F), excursions permitted to 37°C (99°F)

Restricted Drug (California) - Use only as directed. Not for use in humans. Keep out of reach of children.

Approved by FDA under NADA # 048-761

Distributed by:

Zoetis Inc., Kalamazoo, MI 49007

Net wt

 

50 LB (22.68 kg)
Active Ingredient Product of China
Further Processed in the U.S.

40029226

50 LB (22.68 kg)

40025775

2000 LB (907 kg)
Active Ingredient Product of China
Further Processed in the U.S.

51090600

2000 LB (907 kg)

500406/01

CPN: 3690440.5

ZOETIS INC.
333 PORTAGE STREET, KALAMAZOO, MI, 49007
Telephone:   269-359-4414
Customer Service:   888-963-8471
Website:   www.zoetis.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

Copyright © 2024 Animalytix LLC. Updated: 2024-02-27